BioWorld® - Medical Device Daily

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
AGREEMENTS: Name Products Content of Agreement Date
Ontogen Corp. compounds to treat skin development 6/96
diseases
agreement
Protein Design Smart HUM195
development and 2/92
Labs Inc. (now antibody for acute licensing agreement
PDL BioPharma
Inc.)
myelogenous leukemia
PRODUCTS ON MARKET: Toiletries division: Skin care products, body soaps, shampoos, hair
conditioners, hair rinse, hair styling, and bath products
Pharmaceuticals division: Prescription and OTC products
Foods division: chewing gum, confectionaries, powdered drinks and frozen
desserts
PRODUCTS IN DEVELOPMENT: Name Status
KB-195 to treat acute myelogenous
leukemia
in Phase I clinicals
Kaneka Corp.
3-2-4, Nakanoshima, Kita-ku
Osaka 530-8288, Japan
Phone: +81-6-6226-5050; Fax: +81-6-6226-5037
Web: www.kaneka.co.jp; E-mail: info@kaneka.co.jp
KEY PERSONNEL: Masatoshi Takeda; Chairman
Masami Onishi; President
Uichiro Shimomi; Exec. VP
Hideo Yasui; Exec. Officer
Kimikazu Sugawara; Exec. Officer
Yoichi Shima; Exec. Officer
Satomi Takahashi; Exec. Officer
Kiyomi Imou; Exec. Officer
Masatoshi Hatori; Exec. Officer
Toshiji Kanou; Exec. Officer
Toshihiro Suzuki; Exec. Officer
EMPLOYEES: 7,306 employees
HISTORY: Founded in September 1949
FACILITIES: Plants in Takasago, Osaka, Shiga and Kashima
Research institutes:
Life Science R&D Center
Advanced Polymer Materials R&D Center
Polymer Designing & Processing Product Development Center
Electronics R&D Center
Production Technology R&D Center
Foods R&D Center
High Performance Materials Research Laboratories
Additional locations in the U.S. Belgium, Singapore, Malaysia, Australia and
China
STOCK-FINANCIAL HISTORY: Listed on the Tokyo, Osaka and Nagoya stock exchanges
Net sales ¥464.310b (YE 06) compared to ¥438.001b (YE 05)
Net income ¥28.100b (YE 06) compared to ¥24.746b (YE 05)
Earnings per share ¥80.80/share (YE 06) compared to ¥70.65/share (YE 05)
Total assets ¥453.159b (YE 06) compared to ¥224.143 (YE 05)
SUBSIDIARIES/DIVISIONS: Kaneka Singapore Co. (Pte.) Ltd.--Singapore (sales and manufacture of
pharmaceutical intermediates)
Kaneka Consulting (Shanghai) Co. Ltd.--China (technical consulting for
Kaneka products)
Copyright ©2006 AHC Media ® 205